The Dermatology Education Foundation (DEF) and the National Psoriasis Foundation (NPF) have partnered together to announce the beginning of a psoriasis educational commitment for dermatology physician assistants and nurse practitioners. Register for the DERM2015 CME...
Patients with psoriasis who were treated with apremilast (Otezla) lost an average of nearly five pounds over a 52-week period, according to results of a pooled analysis published in the Journal of the American Academy of Dermatology....
Video Summary In this joint presentation, Dr. Cohen reviews data for exisitng agents for psoriasis, while Dr. Kircik presents new biologics in psoriasis treatment. Presenters: David Cohen, MD, MPH, FAAD Leon Kircik, MD,...
Use of adalimumab and infliximab for #psoriasis may lead to increased risk of serious infection http://archderm.jamanetwork.com/article.aspx?articleid=2293165
